News | ECG | October 09, 2025

Viz.ai Introduces Viz ACS to Accelerate Treatment for Heart Attack, Reduce Unnecessary Activations

New solution helps reduce false activations through real-time data sharing and team coordination.

Viz.ai Introduces Viz ACS to Accelerate Treatment for Heart Attack, Reduce Unnecessary Activations

(Photo: Viz.ai)


Oct. 8, 2025 — Viz.ai recently launched  Viz ACS, a new solution in the Viz Cardio Suite. Designed to unite the acute coronary syndrome (ACS) care team on a single platform, Viz ACS provides Emergency Department (ED) physicians and cardiologists with the same high-quality ECGs and patient data in real time. This streamlined workflow can help improve communication, speeds treatment, and reduces unnecessary cath lab activations.

“Viz ACS gives immediate access to ambulance and ED ECGs all in one place,” said Dr. Gregory Means, a practicing interventional cardiologist. “Instead of blurry text messages, I can coordinate with EMS, ED, and cath lab teams in a HIPAA-compliant environment, and activate the cath lab only when needed. This saves time, avoids false alarms, and ensures patients are ready for percutaneous coronary intervention (PCI) as soon as they arrive.”

Viz ACS consolidates ECGs from the ambulance, emergency department, and prior encounters into a HIPAA-compliant mobile viewer, giving cardiologists immediate access to a patient’s full history to track serial changes and interpret the latest ECG in context. When a heart attack is suspected, ED teams can escalate directly to the on-call interventional cardiologist, who can review ECGs and patient data in real time and activate the cath lab with a single click.This secure, streamlined workflow replaces screenshots and fragmented text chains with improved coordination across the care team.

“From our earliest work in stroke, Viz has focused on harnessing technology to give physicians the tools they need to act faster and coordinate care when every second counts,” said Dr. Andrew M. Ibrahim, MD, MSc, chief clinical officer at Viz.ai. “With Viz ACS, we’re expanding that commitment into cardiology, bringing the same proven approach to acute cardiac conditions where speed is critical. The addition of ACS is another step toward our vision of an enterprise-wide solution that spans specialties—making it easier for health systems to care for every patient, in every corner of healthcare.”

To learn more about Viz ACS, visit viz.ai/viz-acs.


Related Content

News | ECG

March 4, 2026 — HeartBeam, Inc. has announced a commercial partnership with ClearCardio. In addition to serving as ...

Home March 06, 2026
Home
News | ECG

March 3, 2026 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for treating cardiovascular and ...

Home March 04, 2026
Home
News | ECG

Feb. 10, 2026 – AccurKardia, a provider of ECG-based diagnostics technology, recently announced results from a new study ...

Home February 24, 2026
Home
News | ECG

Feb. 18, 2026 — Researchers at the Mount Sinai Kravis Children’s Heart Center led a multicenter effort to develop and ...

Home February 20, 2026
Home
News | ECG

Dec. 10, 2025 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to HeartBeam, Inc. for its 12 ...

Home February 16, 2026
Home
News | ECG

Jan. 8, 2026 — AccurKardia recently announced U.S. Food and Drug Administration (FDA) 510(k) clearance and the ...

Home January 15, 2026
Home
News | ECG

Jan. 13, 2026 — AliveCor has received U.S. Food and Drug Administration (FDA) clearance for the next generation of KAI ...

Home January 14, 2026
Home
News | ECG

Aug. 14, 2025 — During HeartBeam, Inc.'s second quarter 2025 earnings conference call, the medical technology company ...

Home August 15, 2025
Home
News | ECG

July 24, 2025 — Royal Philips has announced a collaboration with Epic to integrate Philips’ suite of cardiac ambulatory ...

Home July 24, 2025
Home
News | ECG

July 17, 2025 — Royal Philips, a global leader in health technology, has launched the Philips ECG AI Marketplace, a ...

Home July 17, 2025
Home
Subscribe Now